One, the production cost of drugs is high
The research and development, production and marketing of drugs cost huge sums of money. Drug research and development requires a large number of laboratory studies and clinical trials, which cost a lot of human, material and financial resources. At the same time, the production of pharmaceuticals requires the use of high-end equipment and technology, which are also very expensive to invest in. In addition, the production process of pharmaceuticals requires compliance with various laws, regulations and quality standards, which also increases production costs.
Two, the high operating costs of medical institutions
The operating costs of medical institutions are also one of the reasons for the high prices of medicines. Medical institutions need to pay staff salaries, medical equipment and medical supplies procurement costs, rent, utilities and other costs, which is passed on to the price of drugs. These costs are especially high for large general hospitals. In addition, medical institutions also need to invest huge sums of money for health epidemiology, medical quality control, etc., which is also part of the operating costs of medical institutions.
Third, the cost of drug distribution
Drugs in the circulation process, but also need to go through various links of intermediaries, such as wholesalers, retailers, agents, etc., each link needs to extract a portion of the profits, and ultimately make the price of drugs remain high.
Four, the drug pricing system
In the country, the pricing of drugs by the state for the unified regulations, drug prices are 0 difference, but the system of drug pricing there are shortcomings. First of all, the price adjustment is slow, and it often takes several years or even longer to make an adjustment, resulting in price lag. Second, the high cost of research and development and production of drugs, while the price of drugs is limited by national policy, which makes it difficult to make a profit and leads to a lack of market supply of some drugs.
Therefore, to reduce the price of drugs, we need to start from several aspects. First, the state should speed up the adjustment of drug prices to ensure that drug prices match production costs. Secondly, it needs to optimize the operating environment of medical institutions, reduce the operating costs of medical institutions, so as to reduce drug prices. At the same time, it is necessary to optimize the circulation of drugs and reduce the profit extraction of intermediate links. Finally, the drug pricing system needs to be improved to better balance the relationship between drug prices and R&D and production costs. Only with the efforts of many parties can we really reduce the price of drugs, so that more people can benefit.